PXL065

DRUG2 trials

Sponsors

Poxel SA

Conditions

ALD (Adrenoleukodystrophy)NASH - Nonalcoholic Steatohepatitis

Phase 2

Study of PXL065 in Patients With Nonalcoholic Steatohepatitis (NASH)

CompletedNCT04321343

Poxel SANASH - Nonalcoholic Steatohepatitis

Start: 2020-09-01End: 2022-06-20Updated: 2023-08-29

Study to Assess PXL065 in Subjects With Adrenomyeloneuropathy (AMN) Form of X-linked Adrenoleukodystrophy (X-ALD or ALD)

WithdrawnNCT05200104

Poxel SAALD (Adrenoleukodystrophy)

Start: 2023-09-30End: 2024-09-30Updated: 2024-12-16